NCT03739411View on ClinicalTrials.gov

Hyperpolarized Imaging in Diagnosing Participants With Glioma

PHASE1RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 9, 2015

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
Glioma
Interventions
RADIATION

Hyperpolarized Carbon C 13 Pyruvate

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

RADIATION

Radiation Therapy

Undergo radiation therapy for cancer outside of this study.

DRUG

Chemotherapy

Undergo chemotherapy for cancer outside of this study.

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Susan Chang

OTHER